FDA Gastroenterology Drugs Division Headed By Harvey; Phase-Out Of ODE V Complete
This article was originally published in The Pink Sheet Daily
Executive Summary
Harvey brings GI experience from the device center as former Gastroenterology & Renal Devices Branch reviewer. His appointment comes as FDA is eliminating the Office of Drug Evaluation V under the reorganization of the Office of New Drugs.